Coho Therapeutics Overview

  • Founded
  • 2019
Founded
  • Status
  • Private
  • Latest Deal Type
  • Seed
  • Investors
  • 2

Coho Therapeutics General Information

Description

Developer of molecular glues designed to degrade proteins that can cause cancer, neurodegeneration, and other serious diseases. The company is developing medicines within a new class of therapeutics, allowing healthcare professionals in preventing various lethal diseases.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • San Diego, CA
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Coho Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round Completed Startup
1. Early Stage VC 01-Jan-2019 Completed Startup
To view Coho Therapeutics’s complete valuation and funding history, request access »

Coho Therapeutics Board Members (1)

Name Representing Role Since
Jayson Punwani Ph.D Self Board Member 000 0000
To view Coho Therapeutics’s complete board members history, request access »

Coho Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Takeda Ventures Corporate Venture Capital Minority 000 0000 000000 0
Osage University Partners Venture Capital Minority 000 0000 000000 0
To view Coho Therapeutics’s complete investors history, request access »